Rapid antimicrobial susceptibility testing to optimize bacteremia treatment

Watch now

Bacteremia, the presence of bacteria in the bloodstream, can lead to severe complications if not promptly diagnosed and treated. Despite advances in diagnostic methods and antimicrobial susceptibility testing (AST), mortality and morbidity rates for patients with bloodstream infections remain high. Rapid AST is crucial for optimizing treatment decisions and combating antimicrobial resistance (AMR), yet delays in reporting positive blood cultures continue to impact patient outcomes.

In this webinar, Dr. Jerina Boelens, Medical Department Head, Clinical Biologist, University of Ghent, will explore the latest innovations in rapid AST and discuss strategies to enhance communication for faster, more effective clinical interventions. She will also provide an update on recent developments aimed at accelerating reporting processes, ensuring that healthcare professionals can act swiftly to improve patient care and combat AMR.

Key learning objectives

• Tips and tricks to speed up the diagnostic work-up of positive blood cultures
• Optimization of antimicrobial therapy through effective communication

Who should attend?

Clinical microbiologists, infectious disease physicians and pharmacists, clinical laboratory scientists, and antimicrobial stewardship committee members.

Certificate of attendance
A certificate of attendance is available for webinar viewers. To request yours, email editor@selectscience.net after viewing the webinar.

Webinar details

• Cost: Free to attend
• Location: Online
• Duration: 60 minutes

Missed the live event?
Register now to access the full webinar and hear all the insights shared during the discussion.